2-240788191-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP2PP5
The NM_001244008.2(KIF1A):c.223C>T(p.Arg75Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000626 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000065 ( 0 hom. )
Consequence
KIF1A
NM_001244008.2 missense
NM_001244008.2 missense
Scores
5
10
4
Clinical Significance
Conservation
PhyloP100: 4.16
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), KIF1A. . Gene score misZ 5.1579 (greater than the threshold 3.09). Trascript score misZ 5.0191 (greater than threshold 3.09). GenCC has associacion of gene with neuropathy, hereditary sensory, type 2C, hereditary spastic paraplegia 30, syndromic intellectual disability, intellectual disability, autosomal dominant 9, PEHO syndrome, autosomal dominant non-syndromic intellectual disability, hereditary sensory and autonomic neuropathy type 2.
PP5
Variant 2-240788191-G-A is Pathogenic according to our data. Variant chr2-240788191-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 191158.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Pathogenic=1, Uncertain_significance=5}. Variant chr2-240788191-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF1A | NM_001244008.2 | c.223C>T | p.Arg75Trp | missense_variant | 4/49 | ENST00000498729.9 | NP_001230937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF1A | ENST00000498729.9 | c.223C>T | p.Arg75Trp | missense_variant | 4/49 | 5 | NM_001244008.2 | ENSP00000438388 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000643 AC: 16AN: 248744Hom.: 0 AF XY: 0.0000888 AC XY: 12AN XY: 135104
GnomAD3 exomes
AF:
AC:
16
AN:
248744
Hom.:
AF XY:
AC XY:
12
AN XY:
135104
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461530Hom.: 0 Cov.: 35 AF XY: 0.0000619 AC XY: 45AN XY: 727060
GnomAD4 exome
AF:
AC:
95
AN:
1461530
Hom.:
Cov.:
35
AF XY:
AC XY:
45
AN XY:
727060
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74336
GnomAD4 genome
AF:
AC:
6
AN:
152176
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:6
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:3
Likely pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | The KIF1A c.223C>T; p.Arg75Trp variant (rs778224699) is reported in an individual with ataxia, dystonia, spasticity and/or myotonia (Abouelhoda 2016) and two individuals with spastic paraplegia (Mereaux 2022), but has also been described in an individual with an alternative molecular explanation for disease (Charles Bronson 2021). This variant is reported in ClinVar (Variation ID: 191158) and is found in the general population with an overall allele frequency of 0.006% (17/280,134 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.653). Due to limited information, the clinical significance of the p.Arg75Trp variant is uncertain at this time. References: Abouelhoda et al. Clinical genomics can facilitate countrywide estimation of autosomal recessive disease burden. Genet Med. 2016 Dec;18(12):1244-1249. PMID: 27124789. Charles Bronson S et al. A Novel Synergistic Association of Variants in PTRH2 and KIF1A Relates to a Syndrome of Hereditary Axonopathy, Outer Hair Cell Dysfunction, Intellectual Disability, Pancreatic Lipomatosis, Diabetes, Cerebellar Atrophy, and Vertebral Artery Hypoplasia. Cureus. 2021 Feb 6;13(2):e13174. PMID: 33717719. Mereaux JL et al. Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain. 2022 Apr 29;145(3):1029-1037. PMID: 34983064. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 13, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2023 | Reported previously in the heterozygous state and co-occurring with a homozygous variant in the PTRH2 gene in a patient with severe axonal involvement and features of infantile-onset multisystem neurologic, endocrine, and pancreatic disease (IMNEPD); however, segregation information was not provided (Charles Bronson et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27124789, 26125038, 21376300, 21820098, 33717719, 33753861, Isa 2022) - |
Intellectual disability, autosomal dominant 9 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
Hereditary spastic paraplegia 30 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 23, 2024 | Variant summary: KIF1A c.223C>T (p.Arg75Trp) results in a non-conservative amino acid change located in the Kinesin motor domain (IPR001752) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 248744 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in KIF1A causing NESCAV Syndrome, allowing no conclusion about variant significance. c.223C>T has been reported in the literature in heterozygous individuals affected with intellectual disability with or without other clinical feaures (Charles Bronson_2021, Chen_2021). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33717719, 33753861, 34983064). ClinVar contains an entry for this variant (Variation ID: 191158). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
KIF1A-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 26, 2024 | The KIF1A c.223C>T variant is predicted to result in the amino acid substitution p.Arg75Trp. This variant was reported in a patient presenting with global developmental delay, intellectual disability, weakness of upper and lower limbs, and diabetes who also carried a loss of function variant in PTRH2 (Charles Bronson. 2021. PubMed ID: 33717719). It's also been seen in patients with autism and hereditary spastic paraplegia (Chen. 2021. PubMed ID: 33753861, Méreaux. 2022. PubMed ID: 34983064).However, Additional information supporting the KIF1A c.223C>T variant's pathogenicity were not provided. This variant is reported in 0.016% of alleles in individuals of European (Finnish) descent in gnomAD. Of note, this variant has been observed in >100 heterozygotes in gnomad v4 (https://gnomad.broadinstitute.org/variant/2-240788191-G-A?dataset=gnomad_r4). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 75 of the KIF1A protein (p.Arg75Trp). This variant is present in population databases (rs778224699, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of KIF1A-related conditions (PMID: 27124789, 33717719, 33753861). ClinVar contains an entry for this variant (Variation ID: 191158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KIF1A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
D;.;.;.;.;.;.;D;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M;.;.;.;.;.;M;.;.;.;M;.;.
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D;D;.;.;.;.;.;.;.;.;D;.;.
REVEL
Pathogenic
Sift
Uncertain
.;D;D;.;.;.;.;.;.;.;.;D;.;.
Sift4G
Uncertain
.;D;D;.;.;.;.;.;.;.;.;.;.;.
Polyphen
D;.;.;.;.;.;.;D;.;.;.;D;.;.
Vest4
0.45, 0.44
MVP
0.71
MPC
1.8
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at